Sort
35,931 grants matching “parkinsons”
Biomimetic Surface for Neural Implants
$617,327Xinyan Tracy Cui · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · NS
Selective Inhibition of GRP 94 to Treat Ocular Hypertension and Glaucoma
$617,323Brian S J Blagg · University Of Notre Dame · R01 · FY2024 · EY
Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension
$617,084Italo Biaggioni · Vanderbilt University Medical Center · R01 · FY2022 · HL
Prefrontal -> Top Down Contribution to Object Recognition
$617,061Moshe Bar · Massachusetts General Hospital · R01 · FY2009 · EY
IMPACTING MITOCHONDRIAL FUNCTION THROUGH ALTERED PROTEASE ACTIVITY
$617,054Rockland L Wiseman · Scripps Research Institute, The · R01 · FY2023 · NS
GENE REGULATORY EVENTS IN ESTABLISHING MATURE T CELL TOLERANCE
$616,905Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Efficacy of Voice Treatment for Parkinson's Disease
$616,814Lorraine O. Ramig · University Of Colorado · R01 · FY2010 · DC
Significance of Protein Synthesis by the Integrated Stress Response in Neuromodulatory Neurons for Adaptive Behavior and Synaptic Plasticity
$616,775Nicole Calakos · Duke University · R01 · FY2025 · NS
CYClical Lower Extremity exercise for Parkinsons trial (CYCLE Trial)
$616,754Jay L Alberts · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · NS
Identifying Targets for Fall-prevention Rehabilitation in People with Parkinsonâs Disease
$616,671Daniel Soren Peterson · Arizona State University-Tempe Campus · R01 · FY2025 · AG
Mechanisms and indicators of inflammasome signaling in Parkinsonâs disease
$616,414Matthew Charles Havrda · Dartmouth College · R01 · FY2022 · ES
NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESE NEUROTOXICITY
$616,410Susan Criswell · Washington University · R01 · FY2020 · ES
Pathophysiological studies of Parkinson's disease dementia
$616,352Huaibin Cai · National Institute On Aging · ZIA · FY2020 · AG
Neuroprotective And Neurorestorative Signaling Mechanisms
$616,305Mark Mattson · National Institute On Aging · ZIA · FY2009 · AG
Neuromodulator signaling and activity in the C. elegans egg-laying circuit
$616,225Michael R Koelle · Yale University · R01 · FY2024 · NS
Identifying causal genetic variants and molecular mechanisms impacting mental health
$616,220Stephen Montgomery · Stanford University · R01 · FY2022 · MH
Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease.
$616,200Michael J Beckstead · Oklahoma Medical Research Foundation · R01 · FY2025 · NS
IDENTIFICATION OF AXONAL DEGENERATION PATHWAYS
$616,200Aaron Diantonio · Washington University · R01 · FY2014 · NS
Chronic physiologic and behavior changes induced by novel STN DBS patterns for PD
$616,031Kenneth B Baker · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · NS
Mechanisms of Synaptic Dysfunction in Parkinson s and Other Synuclein-Linked Diseases
$616,013Jennifer R Morgan · Marine Biological Laboratory · R01 · FY2025 · NS
Identifying causal genetic variants and molecular mechanisms impacting mental health
$615,969Stephen Montgomery · Stanford University · R01 · FY2023 · MH
Identifying causal genetic variants and molecular mechanisms impacting mental health
$615,969Stephen Montgomery · Stanford University · R01 · FY2024 · MH
DRUG DISCOVERY CORE FACILITY (DDCF)
$615,763Kinfe Ken Redda · Florida Agricultural And Mechanical Univ · G12 · FY2009 · RR
High-speed opto-fluidics to screen entire nervous system in aging and disease
$615,663Adela Ben-Yakar · University Of Texas At Austin · R01 · FY2011 · AG
Mechanisms of gene regulation and RNA processing in synucleinopathies
$615,591Joseph R Mazzulli · Northwestern University At Chicago · R01 · FY2021 · NS